1 / 15

Efter blodproppen - Hvad ved vi om betydningen af comorbiditet hos hjertepatienten?

Efter blodproppen - Hvad ved vi om betydningen af comorbiditet hos hjertepatienten?. Mogens Lytken Larsen Ledende overlæge, dr.med Hjertemedicinsk afdeling B. Comorbiditet hos hjertepatienten. Diabetes Mellitus Metabolisk syndrom Nedsat glukose tolerans KOL og Tobak Nyresygdom

linda-hicks
Download Presentation

Efter blodproppen - Hvad ved vi om betydningen af comorbiditet hos hjertepatienten?

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Efter blodproppen- Hvad ved vi om betydningen af comorbiditet hos hjertepatienten? Mogens Lytken Larsen Ledende overlæge, dr.med Hjertemedicinsk afdeling B

  2. Comorbiditet hos hjertepatienten • Diabetes Mellitus • Metabolisk syndrom • Nedsat glukose tolerans • KOL og Tobak • Nyresygdom • Depression og angst

  3. Aim: To ascertain the prevalence of impaired glucose metabolism in patients without diagnosed diabetes but with MI GLUKOMETABOLISME og ISKÆMISK HJERTESYGDOM Norhammar, Lancet 2002; 359: 2140–44

  4. MORTALITET EFTER AMI (SVENDBORG 2003-2006) n = 403; P<0,001 Kendt DM Nyopdaget DM IGT Normal

  5. European Heart J 2004

  6. 8 ▪ www.regionmidtjylland.dk

  7. * Estimated GFR < 60mL/min

  8. Prevalence of Depression in Chronic Disease NHDS, NAMCS, NHAMCS Sutor B, et al. Mayo Clin Proc. 1998;73(4):329-337; Jiang et al, CNS Drugs, 2002

  9. Depression and Cardiovasular Mortality Post-MI: 6 and 18 month outcome Adjusted RR: at 6 mos = 3.10; at 18 mos: 3.64 % of coronary deaths Frasure-Smith N, et al. JAMA 1993;270:18191825. Frasure-Smith N, et al. Circulation 1995;91:9991005.

  10. Comorbiditet hos hjertepatienten • Diabetes Mellitus 35% • Nedsat glukose tolerans 31% • KOL 22% • Nyresygdom 24% • Depression og angst 22%

More Related